Von Hippel–Lindau disease: insights into oxygen sensing, protein degradation, and cancer

WG Kaelin - The Journal of Clinical Investigation, 2022 - jci.org
Germline loss-of-function mutations of the VHL tumor suppressor gene cause von Hippel–
Lindau disease, which is associated with an increased risk of hemangioblastomas, clear cell …

2-Oxoglutarate-dependent dioxygenases in cancer

JA Losman, P Koivunen, WG Kaelin Jr - Nature Reviews Cancer, 2020 - nature.com
Oxoglutarate-dependent dioxygenases (2OGDDs) are a superfamily of enzymes that play
diverse roles in many biological processes, including regulation of hypoxia-inducible factor …

Single-cell transcriptomics of human embryos identifies multiple sympathoblast lineages with potential implications for neuroblastoma origin

P Kameneva, AV Artemov, ME Kastriti, L Faure… - Nature …, 2021 - nature.com
Abstract Characterization of the progression of cellular states during human embryogenesis
can provide insights into the origin of pediatric diseases. We examined the transcriptional …

Saturation genome editing maps the functional spectrum of pathogenic VHL alleles

M Buckley, C Terwagne, A Ganner, L Cubitt, R Brewer… - Nature …, 2024 - nature.com
To maximize the impact of precision medicine approaches, it is critical to identify genetic
variants underlying disease and to accurately quantify their functional effects. A gene …

Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline

JWM Lenders, QY Duh, G Eisenhofer… - The Journal of …, 2014 - academic.oup.com
Objective: The aim was to formulate clinical practice guidelines for pheochromocytoma and
paraganglioma (PPGL). Participants: The Task Force included a chair selected by the …

VHL, the story of a tumour suppressor gene

L Gossage, T Eisen, ER Maher - Nature Reviews Cancer, 2015 - nature.com
Abstract Since the Von Hippel–Lindau (VHL) disease tumour suppressor gene VHL was
identified in 1993 as the genetic basis for a rare disorder, it has proved to be of wide medical …

Metabolic reprogramming: a cancer hallmark even warburg did not anticipate

PS Ward, CB Thompson - Cancer cell, 2012 - cell.com
Cancer metabolism has long been equated with aerobic glycolysis, seen by early
biochemists as primitive and inefficient. Despite these early beliefs, the metabolic signatures …

Cancer cell metabolism: one hallmark, many faces

JR Cantor, DM Sabatini - Cancer discovery, 2012 - aacrjournals.org
Cancer cells must rewire cellular metabolism to satisfy the demands of growth and
proliferation. Although many of the metabolic alterations are largely similar to those in …

[HTML][HTML] Cellular metabolism and disease: what do metabolic outliers teach us?

RJ DeBerardinis, CB Thompson - Cell, 2012 - cell.com
An understanding of metabolic pathways based solely on biochemistry textbooks would
underestimate the pervasive role of metabolism in essentially every aspect of biology. It is …

Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity

PLM Dahia - Nature Reviews Cancer, 2014 - nature.com
The neuroendocrine tumours pheochromocytomas and paragangliomas carry the highest
degree of heritability in human neoplasms, enabling genetic alterations to be traced to …